The carcinogenic potential of prednisone, a synthetic corticosteroid used as an anti-inflammatory and immunosuppressive agent, was investigated by feeding it to Cr1:CD-1(ICR) mice (50/sex/dose) at doses of 0.25, 0.50, 1.0, and 5.0 mg/kg/day for 18 months. Prednisone did not significantly increase the incidence of neoplasms (p ≤ 0.05); on the contrary, it significantly decreased the incidence of hepatocellular tumors (p = 0.002 in males, p = 0.027 in females), male lacrimal/Harderian gland tumors (p = 0.05), female pulmonary adenomas (p = 0.047), female endothelial cell tumors (p = 0.035), and female lymphosarcomas (p = 0.02). This study suggests that long-term (lifetime) prednisone use does not increase cancer risk and may actually reduce it.
Anbari N., Schklar G., and Cataldo E. (1965). The effect of systemically administered cortisone on salivary gland carcinogenesis in the rat. J. Dental Res . 44: 1056-1061.
2.
Bailer AJ and Portier CJ (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics44: 417-431.
3.
Berger MR, Habs M., and Schmähl D. (1986). Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisone, and chlorambucil plus prednisone in Sprague-Dawley rats. Seminars Oncol. 13: 8-13.
4.
Chaudhry AP and Schmutz JA (1966). Effects ofprednisolone and thalidomide on induced submandibular gland tumors in hamsters. Cancer Res. 26: 1884-1886.
5.
Colburn WA, Sibley CR, and Buller RH (1976). Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to Beagle dogs. J. Pharmacol. Sci. 65: 997-1001.
6.
Committee on Care and Use of Laboratory Animals ( 1985). Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services .
7.
Committee on Diet, Nutrition, and Cancer ( 1982). Diet, Nutrition, and Cancer. National Academy Press, Washington, D.C., pp. 1-129.
8.
Cotter SM (1977). Feline virus-associated diseases. In: Current Veterinary Therapy VI. Small Animal Practice, RW Kirk (ed). W. B. Saunders Company , Philadelphia, pp. 465-472.
9.
El Dareer SM , Struck RF, White VM, Mellett LB, and Hill DL (1977). Distribution and metabolism of prednisone in mice, dogs, and monkeys. Cancer Treat Rep . 61: 1279-1289.
10.
Gart JJ, Krewski B., Lee PN, Tarone RE, and Wahrendorf J. (1986). Statistical Methods in Cancer Research Volume III: The Design and Analysis of Long-Term Animal Experiments. International Agency for Research on Cancer, Lyon, pp. 94-101.
11.
Gellatly JBM (1975). The natural history of hepatic parenchymal nodule formation in a colony of C57BL mice with reference to the effect of diet. In: Mouse Hepatic Neoplasia, WH Butler and PM Newberne (eds). Elsevier Scientific Publishing Company, Amsterdam, pp. 77-109.
12.
Gilman AG and Murad F. (1975). Adenohypophyseal hormones and related substances . In: The Pharmacological Basis of Therapeutics, 5th ed., LS Goodman and A Gilman (eds). MacMillan Publishing Co., Inc., New York, pp. 1372-1506.
13.
Heilman FR and Kendall EC (1944). The influence of 11-dehydro-17-hydroxycorticosterone (Compound E) on the growth of a malignant tumor in the mouse. Endocrinology34: 416-420.
14.
Huggins CB and Uematsu K. (1976). Induction of lymphatic leukemia in non-inbred mice and and its control with glucocorticoids. Cancer37: 177-180.
15.
Jenkins JS and Sampson PA (1967). Conversion of cortisone to cortisol and prednisone to cortisol and to prednisolone. Br. Med. J. ii: 205-207.
16.
Koranda FC, Loeffler RT, Koranda DM, and Penn I. (1975). Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg. Forum26: 145-146.
17.
MacEwen EG and Hess PW (1977). Canine lymphosarcoma and leukemia. In: Current Veterinary Therapy VI. Small Anitnal Practice, RW Kirk (ed). W. B. Saunders Company , Philadelphia, pp. 473-479.
18.
McConnell EE , Solleveld HA, Swenberg JA, and Boorman GA (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J. Natl. Cancer Inst. 76: 283-289.
19.
Miller RG (1981). Survival Analysis. John Wiley , New York, pp. 107-118.
20.
Nielsen SW (1978). Diseases of skin. In: Pathology of Laboratory Animals, Vol. I, K Benirschke , FM Gamer, and TC Jones (eds). Springer-Verlag, New York, pp. 561-618.
Rogers AE and Longnecker MP (1988). Dietary and nutritional influences on cancer: A review of epidemiologic and experimental data. Lab. Invest . 59: 729-759.
23.
Ruberg SJ (1989). Contrasts for identifying the minimum effective dose. J. Am. Statist Assoc. 84: 816-822.
24.
Sabes WR, Chaudhry AP, and Gorlin RJ (1963). Effects of cortisone on chemical carcinogenesis in hamster pouch and submandibular salivary gland. J. Dental Res. 42: 1118-1130.
25.
Shklar G. (1966). Cortisone and hamster buccal pouch carcinogenesis . Cancer Res. 26: 2461-2463.
26.
Steel RGD and Torrie JH (1980). Principles and Procedures of Statistics, 2nd ed. McGraw Hill Book Company, New York, pp. 182-183.
27.
Tizard IR (1977). An Introduction to Veterinary Immunology. W. B. Saunders Company, Philadelphia, PA , pp. 253.
28.
Tukey JW, Ciminera JL, and Heyse JF (1985). Testing the statistical certainty of a response to increasing doses of a drug. Biometrics41: 297-301.
29.
Wagner G., Habs M., and Schmähl D. (1982). Influence of daily subcutaneous administration of 6-methyl-prednisolone and oral application of 30%, saline solution on tumorigenesis induced in mouse stomach by single application of 7,12-dimethylbenz(a)anthracene . J. Cancer Res. Clin. Oncol.103: 207-209.
30.
Weisburger EK (1977). Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents. Cancer40: 1935-1949.
31.
Westfall PH and Young SS (1989). P-value adjustments for multiple tests in multivariate binomial models. J. Am. Statist Assoc. 84: 780-786.
32.
Woodworth BA , Scribner JD, and Scribner NK (1986). Enhancement of β-propiolactone tumorigenesis in niouse skin by pretreatment with the anti-inflammatory steroid fluocinolone acetonide. Cancer Letts. 31: 293-297.
